Experience the fascinating world of tablet and capsule dissolution with 'eLapse.' This video presents close-up time-lapse ...
SAN DIEGO, March 9, 2023 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced it will present data from three in vitro dissolution studies exploring the dissolution performance ...
Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ is voluntarily recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K, to the consumer level. The product is being ...
(RTTNews) - Mahwah, New Jersey-based Glenmark Pharmaceuticals Inc., USA is recalling 114 batches of Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEq K citing failed dissolution, ...
At this time, there have been no reports of injury related to this recall. Glenmark Pharmaceuticals is recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750mg) 10 mEq K due ...
More than 130 batches of potassium chloride capsules, prescribed to those with hypokalaemia, have been recalled for a dissolution issue that could elevate potassium to life-threatening levels, ...
InformNNY on MSN
Cholesterol medication recalled over ‘failed dissolution specifications’: What to know
Over 141,000 bottles of cholesterol medication have been recalled due to “failed dissolution specifications,” suggesting that the drugs did not pass a solubility test, or failed to dissolve at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results